This is an excellent report written by Steve Laczniak of The Department of Engineering Physics at The University of Wisconsin, Madison, US
It is a fairly long report so I have split it into a few posts together on this thread.
The report is a great overview of The Verichip and essential reading for people new to the topic. I have copied and reformatted this report for the purpose of this thread from the original PDF file of the report here -
http://tc.engr.wisc.edu/Wunsch/Laczniak ... 202006.pdf
A “VeriChip” on Society’s Shoulder
Positive and Negative Implications of the VeriChip©
Steve Laczniak
Department of Engineering Physics
University of Wisconsin-Madison
Executive Summary
On October 12, 2004, the Food and Drug Administration approved the VeriChip for medical use. The VeriChip (a tiny, human-implantable RFID tag) may offer some people safety and convenience; but, many others find the device unsettling.
While the VeriChip can play an important—even life-saving—role in the healthcare sector, the sub-dermal RFID tag makes potential users more vulnerable to privacy loss.
In medicine, the VeriChip primarily functions as a tool for managing patient information.
Specifically, the chip allows healthcare professionals to quickly and accurately ascertain critical patient information. The device, which contains only a unique serial number, is linked to a patient database maintained by a hospital.
Typically, the database information
would include a person’s name, address, current medications, known allergies and critical medical history. Key constituents who would benefit from a VeriChip include anyone with impaired speech, memory loss or chronic loss of consciousness. These conditions create a communication barrier that could delay treatment or even result in medical
errors. To remedy this situation, the VeriChip conveys pertinent information when the patient is unable to do so. In this manner, the VeriChip fills a possible information gap in
the healthcare sector, and the device should be considered as a preventative tactic for atrisk individuals. Already, hospitals are accepting the technology.
As of October 3, 2005, fifty-eight hospitals across the United States have agreed to implement a patient identification VeriChip system in their emergency rooms.
Interlocking databases remain a concern with respect to VeriChip systems. Critics of the device contend that these VeriChip databases may become linked to other private and public databases. These interlocking databases make complete profiles on any consumer available. Such biographical sketches might include name, address, social security
number, credit reports and—with the addition of VeriChip databases—even medical records. Companies, such as the data broker ChoicePoint, will start maintaining databases of RFID numbers and their associated parties. The problem is that these aggregate databases are a tempting target for criminals. Also, companies who gain access to the information could use it surreptitiously to make employment decisions. In
February, ChoicePoint accidentally sold confidential information on 145,000 people to identity thieves posing as legitimate businessmen.
Introducing the VeriChip creates the potential for a person’s medical history to be included in these cumulative databases.
In the end, consumers have little reassurance that VeriChip databases will remain private and separated from other databases and data brokers. Consumers considering the VeriChip should be weary as their personal information will be at the discretion of whoever controls the accompanying VeriChip database.
Introduction
Fig 1 Barcelona nightclub
In March 2004, a Barcelona nightclub started offering VeriChip services to its regular clients. Revelers with the implanted microchip could use the device to bypass entry lines and manage their bar tabs (See Figure 1).
A few months later, on October 12, 2004, the Food and Drug Administration (FDA) approved the VeriChip for medical purposes.
With medical use already approved in the United States and plans for security and financial applications underway, the VeriChip Corporation—the company that makes the VeriChip—is looking to grow its
product in the coming years. While the VeriChip may offer some people
safety and convenience, the device appears unsettling to others.
For instance, John L. Peterson, a security expert and futurist at the Arlington Institute in Washington D.C., commented on the chipping of
humans: “In a decade or two, there
will be a commonly available system with the ability to know who people
are, where they are and what they’ve done” (Murray, 2004, p. 1).
Is the VeriChip a first step towards the “Big Brother” society that Peterson
predicts? Or, is the VeriChip a device that can provide added convenience to consumers?
This technical report will focus on the impact that a VeriChip system will have on society. In other words, this document will address the positive and negative implications of the VeriChip. Indeed, the VeriChip offers a number of beneficial uses for consumers.
In the ER: The device functions as a means of communicating critical healthcare information for patients who are incapable of speaking. For instance, a VeriChip tied to a medical database could be lifesaving for an unconscious patient in the emergency room.
The emergency room technicians could scan the victim’s VeriChip and instantly receive information about the patient’s current medications, known allergies and primary caregiver ( http://www.verichipcorp.com/ )
continued.....


News